Your browser doesn't support javascript.
loading
Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
Nasioudis, Dimitrios; Mastroyannis, Spyridon A; Haggerty, Ashley F; Giuntoli, Robert L; Morgan, Mark A; Ko, Emily M; Latif, Nawar A.
Afiliação
  • Nasioudis D; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA. Electronic address: dimitrios.nasioudis@uphs.upenn.edu.
  • Mastroyannis SA; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • Haggerty AF; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • Giuntoli RL; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • Morgan MA; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • Ko EM; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • Latif NA; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
Eur J Obstet Gynecol Reprod Biol ; 248: 63-70, 2020 May.
Article em En | MEDLINE | ID: mdl-32182501
ABSTRACT

OBJECTIVE:

To investigate the safety of uterine preservation in patients with high-grade epithelial ovarian carcinoma (EOC). STUDY

DESIGN:

The Surveillance, Epidemiology, and End Results database was accessed (1988-2014) and patients aged < = 45 years, diagnosed with an unilateral high-grade non-clear cell EOC confined to the ovary were selected. Based on surgery codes we determined whether hysterectomy was performed. Overall (OS) and cancer-specific survival (CSS) was estimated calculated following generation of Kaplan-Meier curves and compared using the log-rank test. Cox hazard model was constructed to control for possible confounders.

RESULTS:

A total of 1039 patients with a median follow-up of 119 months were identified. Rate of uterine preservation was 31.8 %. Patients who had hysterectomy were older (median 41 vs 32 yrs, p < 0.001). Patients with mucinous tumors were less likely to undergo hysterectomy (58.9 %) compared to those with endometrioid (73.9 %) and serous (75.9 %) carcinoma, p < 0.001. There was no difference in CSS between patients who did and did not have hysterectomy, p = 0.70 (5-yr rates were 93.9 % vs 92.2 %, respectively). After controlling for year of diagnosis, tumor histology (serous vs non-serous), disease stage, performance of lymph node dissection (LND) and tumor grade, uterine preservation was not associated with a worse cancer-specific (HR 1.08, 95 % CI0.69,1.71) and overall (HR0.88, 95 % CI 0.59, 1.32) mortality.

CONCLUSION:

In this retrospective cohort of patients with unilateral high-grade non-clear cell EOC confined to the ovary, uterine preservation was not associated with a worse prognosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Tratamentos com Preservação do Órgão / Carcinoma Epitelial do Ovário Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Eur J Obstet Gynecol Reprod Biol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Tratamentos com Preservação do Órgão / Carcinoma Epitelial do Ovário Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Eur J Obstet Gynecol Reprod Biol Ano de publicação: 2020 Tipo de documento: Article